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Abstract
 
The contribution of the NADPH phagocyte oxidase (phox) and inducible nitric oxide (NO)
synthase (iNOS) to the antimicrobial activity of macrophages for 
 
Salmonella typhimurium
 
 was
studied by using peritoneal phagocytes from C57BL/6, congenic gp91
 
phox
 
2
 
/
 
2
 
, 
 
iNOS
 
2
 
/
 
2
 
, and
doubly immunodeficient 
 
phox
 
2
 
/
 
2
 
iNOS
 
2
 
/
 
2
 
 mice. The respiratory burst and NO radical (NO
 
?
 
)
made distinct contributions to the anti-
 
Salmonella
 
 activity of macrophages. NADPH oxidase–
dependent killing is confined to the first few hours after phagocytosis, whereas iNOS contrib-
utes to both early and late phases of antibacterial activity. NO-derived species initially synergize
with oxyradicals to kill
 
 S
 
.
 
 typhimurium
 
, and subsequently exert prolonged oxidase-independent
bacteriostatic effects. Biochemical analyses show that early killing of 
 
Salmonella
 
 by macrophages
coincides with an oxidative chemistry characterized by superoxide anion (O
 
2
 
?
 
2
 
), hydrogen
peroxide (H
 
2
 
O
 
2
 
), and peroxynitrite (ONOO
 
2
 
) production. However, immunofluorescence
microscopy and killing assays using the scavenger uric acid suggest that peroxynitrite is not re-
sponsible for macrophage killing of wild-type 
 
S
 
.
 
 typhimurium
 
. Rapid oxidative bacterial killing
is followed by a sustained period of nitrosative chemistry that limits bacterial growth. Interferon
 
g
 
 appears to augment antibacterial activity predominantly by enhancing NO
 
?
 
 production, al-
though a small iNOS-independent effect was also observed. These findings demonstrate that
macrophages kill 
 
Salmonella
 
 in a dynamic process that changes over time and requires the gen-
eration of both reactive oxidative and nitrosative species.
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Introduction
 
Salmonella
 
 pathogenesis commences in the ileal mucosa
with invasion of M cells or ingestion by CD18-expressing
phagocytes (1, 2). For the duration of the infection, 
 
Salmo-
nella
 
 can be found principally within mononuclear phago-
cytes (3), which can serve as a vehicle of extraintestinal dis-
semination (1) and as a protected site for intracellular
bacterial replication (3). The capacity to survive within
macrophages is an absolute requirement for 
 
Salmonella
 
 viru-
lence in vivo (4). Macrophages contribute to resistance to
 
Salmonella
 
 by forming granulomas and limiting bacterial
growth (5), but the effector mechanisms by which mono-
nuclear phagocytes combat this intracellular pathogen are
incompletely understood.
Radicals generated by the NADPH oxidase and induc-
ible nitric oxide (NO)
 
1 
 
synthase (iNOS) are cytotoxic for a
variety of microorganisms as phylogenetically diverse as vi-
ruses, bacteria, protozoa, and fungi. The NADPH oxidase
expressed by myeloid cells catalyzes the univalent reduction
of molecular oxygen to O
 
2
 
?
 
2
 
. This radical has only limited
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membrane diffusibility and modest antibacterial activity,
but also serves as a precursor to more toxic reactive oxygen
species (ROS [6]). The critical role of the phagocyte oxi-
dase (phox) is reflected by the enhanced susceptibility of
patients with chronic granulomatous disease to a wide
range of microbial pathogens, including 
 
Salmonella
 
 species
(6–8). Immunodeficient gp91
 
phox
 
2
 
/
 
2
 
 mice, an animal
model for X-linked chronic granulomatous disease (CGD),
are accordingly very susceptible to experimental 
 
Salmonella
typhimurium
 
 infections (9, 10). The reduced killing capacity
of cell lines impaired in their ability to sustain a respiratory
burst further attests to the importance of the NADPH oxi-
dase in the anti-
 
Salmonella
 
 activity of macrophages (11).
NOS isoforms generate NO
 
? 
 
in a complex reaction that
consumes NADPH, oxygen, and 
 
l
 
-arginine (12). NO
 
?
 
 by
itself posses only weak antimicrobial activity against 
 
Salmo-
nella
 
 (13), but congeners resulting from NO
 
? 
 
autooxidation
such as NO
 
2
 
?
 
, N
 
2
 
O
 
3
 
, and 
 
S
 
-nitrosothiols (14) enhance its
cytotoxic potential. In addition, concerted actions of the
NADPH oxidase and iNOS can synergize to form highly
potent antimicrobial species. For example, NO
 
?
 
 reacts at a
rate of 6.7 
 
3
 
 10
 
9
 
 M/s with O
 
2
 
?
 
2
 
 to form ONOO
 
2
 
 (15,
16), an oxidant capable of damaging lipids, proteins, and
DNA; ONOO
 
2
 
 has been associated with enhanced killing
of 
 
S
 
.
 
 typhimurium
 
, 
 
Escherichia coli
 
, and 
 
Candida albicans
 
 (13,
17, 18). NO
 
?
 
 can also act in concert with H
 
2
 
O
 
2
 
 to kill 
 
E
 
.
 
coli
 
 in vitro by a mechanism that appears to be at least par-
tially iron dependent (19).
The contribution of NO
 
?
 
 is of particular significance in
resistance to intracellular pathogens. Development of a Th1
immune response dominated by IFN-
 
g
 
, IL-2, and IL-12
synthesis in combination with NO
 
?
 
-mediated effector
functions has been correlated with resistance to 
 
Leishmania
 
and mycobacterial infections (20, 21). Similarly, IFN-
 
g
 
,
IL-12, and TNF-
 
a
 
 production is associated with resistance
to 
 
S
 
.
 
 typhimurium
 
 (22, 23). However, the contribution of
NO
 
?
 
 in innate immunity to 
 
Salmonella
 
 is still a matter of ac-
tive debate. Evidence obtained from several laboratories us-
ing several nitrogen oxide donors such as 
 
S
 
-nitrosoglu-
tathione, acidified NO
 
2
 
2
 
, and ONOO
 
2
 
 has unequivocally
established that 
 
S
 
.
 
 typhimurium
 
 is susceptible to reactive ni-
trogen species (RNS) in vitro (13, 24–26). Furthermore, 
 
S
 
.
 
typhimurium
 
 deficient in DNA repair systems (e.g., 
 
umuC
 
and 
 
recBC
 
), small thiol molecules (e.g., homocysteine and
glutathione), or detoxifying enzymes (e.g., flavohemopro-
tein or copper zinc superoxide dismutase) is hypersuscepti-
ble to NO
 
? 
 
congeners in vitro, and shows reduced mac-
rophage resistance and virulence in vivo (13, 25, 27–29).
Yet, despite this compelling evidence favoring distinct
NO
 
?
 
 actions against 
 
Salmonella
 
, some studies have failed to
demonstrate that NO
 
?
 
 plays a role in macrophage inhibi-
tion or killing of wild-type 
 
S
 
.
 
 typhimurium
 
 (9, 24, 30, 31).
In this work, we employed macrophages from C57BL/6
mice and their congenic 
 
iNOS
 
2
 
/
 
2
 
, gp91
 
phox
 
2
 
/
 
2
 
, and dou-
bly immunodeficient 
 
iNOS
 
2/2gp91phox2/2 derivatives to
elucidate the contributions of the NADPH phagocyte oxi-
dase and iNOS to antibacterial actions of macrophages for
wild-type S. typhimurium.
Materials and Methods
Bacterial Strains. Wild-type  S. typhimurium strains American
Type Culture Collection 14028s (1) and M525P (10, 32) were
used for this study. For immunofluorescence microscopy, rpsM::
gfp was moved by P22-mediated transduction from strain SMO22
(1) into S. typhimurium 14028s to yield S. typhimurium AF991
(gfp1).
Mice. Wild-type C57BL/6 mice were purchased from The
Jackson Laboratory. Congenic iNOS2/2 (33), gp91phox2/2 (34),
and doubly immunodeficient iNOS 2/2gp91phox2/2 (9) mice
were bred in our animal facility according to Institutional Animal
Care and Use Committee guidelines. The iNOS2/2 mice were
the progeny (N3–N5) of mice backcrossed onto a C57BL/6 back-
ground for 10 generations (gift of C. Nathan, Cornell University,
New York, NY). The gp91phox2/2 and iNOS2/2gp91phox2/2
mice were progeny (N4–N6) of mice described previously (9, 34).
gp91phox2/2 and iNOS2/2gp91phox2/2 mice were maintained
on drinking water containing 15 mg/ml itraconazole, 0.2 mg/ml
trimethoprim, and 40 mg/ml sulfamethoxazole up to 4 d before
experimentation to prevent spontaneous infections.
Macrophages. Peritoneal macrophages from C57BL/6 and
congenic  iNOS2/2 (33), gp91phox2/2 (34) and doubly immuno-
deficient iNOS2/2gp91phox2/2 (9) mice were harvested 4 d af-
ter intraperitoneal inoculation of 1 mg/ml sodium periodate as
described (25). The peritoneal exudate cells were resuspended in
RPMI 1640 supplemented with 10% heat-inactivated FCS
(Gemini Bioproducts), 1 mM sodium pyruvate, 10 mM Hepes,
and 2 mM l-glutamine (all reagents from Sigma-Aldrich). The
macrophages were selected by adherence in a 96-well plate and
cultured for 48 h at 378C in a 5%-CO2 incubator. Unless other-
wise indicated, adherent macrophages were treated in vitro over-
night with 20 U/ml of IFN-g (Life Technologies) from a 105 U/ml
stock containing 0.8 ng/ml LPS.
Macrophage Killing Assays. Periodate-elicited macrophages
were challenged with S. typhimurium opsonized with 10% normal
mouse serum at a 10:1 multiplicity of infection, allowed to inter-
nalize the bacteria for 15 min, and washed with prewarmed me-
dium containing 6 mg/ml gentamicin (25). At several time points
after infection, the macrophages were lysed with 0.5% sodium
deoxycholate, and surviving bacteria were enumerated on Luria-
Bertani agar plates. The results are expressed as percentage sur-
vival.
Chemiluminescence. Macrophage chemiluminescence was esti-
mated by the reduction of 25 mM lucigenin (bis-N-methylacri-
dinium) and the oxidation of 100 mM luminol (5-amino-2,3-
dihydro-1,4-phthalazinedione; Sigma-Aldrich) with a Lumistar
chemiluminometer (BMG Lab Technologies) in Microlite flat-
bottomed microtiter plates (Dinex Technologies, Inc.). The macro-
phages were challenged with wild-type S. typhimurium American
Type Culture Collection 14028s as described in the macrophage
killing assays above. Extracellular bacteria were removed by wash-
ing and the addition of 6 mg/ml gentamicin. At specified time
intervals, medium was harvested and replaced by fresh medium
for performance of the assays. Lucigenin and luminol were used
as indicators of O2?2 and ONOO2 production (35, 36), respec-
tively. 1 mM uric acid (37, 38) inhibited z80% of luminol-
dependent chemiluminescence generated by IFN-g–activated pe-
riodate-elicited macrophages 1 h after bacterial challenge, whereas
1,000 U/ml catalase (gift of Dr. S. Libby, North Carolina State
University, Raleigh, NC) inhibited only 20%. These observa-
tions, along with the dependence of chemiluminescence on both
the NADPH oxidase and iNOS, indicate that the majority of this
luminol chemiluminescence is mediated by ONOO2, whereas a229 Vazquez-Torres et al.
minor proportion reflects H2O2. Periodate-elicited macrophages
from wild-type, iNOS2/2, and phox2/2 mice were compared.
Superoxide Anion Determination. O2?2 was quantified by the
superoxide dismutase–inhibitable reduction of ferricytochrome c
(39). At different time points after infection with Salmonella, me-
dium was removed from cultured IFN-g–treated 48 h–aged peri-
odate-elicited macrophages and replaced with fresh medium con-
taining 60 mM ferricytochrome c in phenol red–free Earle’s
balanced salt solution. After 1 h incubation in 5% CO2 at 378C,
the OD of the supernatants was determined spectrophotometri-
cally at 550 nm. The concentration of O2?2 was calculated by us-
ing an e550 of 2.1 3 103 M21 cm21. All reagents were purchased
from Sigma-Aldrich.
Hydrogen Peroxide Determination. H2O2 was measured by the
horseradish peroxidase–dependent oxidation of phenol red (39).
The macrophages were challenged with Salmonella as described
above, and extracellular bacteria were removed by washing and
the addition of gentamicin before incubation in Earle’s balanced
salt solution containing 0.56 mM phenol red and 20 U/ml horse-
radish peroxidase. At indicated time intervals, medium was har-
vested and replaced with fresh medium. After 1 h incubation at
378C in a 5%-CO2 atmosphere, the absorbance of the superna-
tants was read at 600 nm after mixing with 10 ml of 1 N NaOH
per well. H2O2 was quantitated by comparison with a standard
curve prepared with known concentrations of H2O2. All reagents
were purchased from Sigma-Aldrich.
NOX Determination. NO synthesis by periodate-elicited mac-
rophages challenged with Salmonella as described above was esti-
mated by measuring the accumulation of nitrite (NO2
2) and ni-
trate (NO3
2), stable metabolites of the reaction of NO with
oxygen, using the Griess reaction. The NO2
2 present in superna-
tants of Salmonella-infected macrophages was measured spectro-
photometrically at 550 nm after mixing with an equal volume of
Griess reagent (0.5% sulfanilamide and 0.05% N-1-naphthyleth-
ylenediamide hydrochloride in 2.5% acetic acid). The NO2
2
concentration was determined from a standard curve prepared
with NaNO2. The NO3
2 accumulated in the supernatants was
estimated by the Griess reaction after enzymatic reduction of
NO3
2 to NO2
2 (40, 41) in pH 7 sodium phosphate buffer con-
taining 1.6 U/ml nitrate reductase, 16 U/ml glucose dehydroge-
nase, 10 mM NADPH, and 10 mM glucose-6-phosphate. NO3
2
concentration was calculated as the difference between NO2
2 ac-
cumulated in the presence and absence of nitrate reductase. At
designated time points, the NOX concentrations were deter-
mined from S. typhimurium–challenged macrophages cultured for
1 h in serum-free IMDM (Sigma-Aldrich) supplemented with
7.5% minimal essential amino acid solution (Life Technologies),
1% minimal nonessential amino acid solution, 1.1 mM sodium
pyruvate (Life Technologies), 1 mg/ml streptomycin sulfate
(Sigma-Aldrich), 0.5 mg/ml gentamicin (Sigma-Aldrich), 0.6
mg/ml penicillin G (Life Technologies), 0.75% wt/vol dextrose
(Sigma-Aldrich), 0.85% wt/vol NaHCO3 (Sigma-Aldrich), and
1% nutridoma-SP (Boehringer). Low background levels of nitrate
(z1 mM) detected in parallel wells were subtracted to exclude a
contribution by residual levels of nitrate present in the culture
medium.
Immunocytochemistry. Macrophages plated onto sterile cover-
slips were incubated for 48 h at 378C in a 5%-CO2 atmosphere.
The macrophages were stimulated with IFN-g during the last 20 h
and challenged with S. typhimurium strain 14028s as described
above. After 90 min of infection, the coverslips were washed
with PBS, and the cells were fixed with 2% paraformaldehyde in
PBS for 20 min. After extensive washing with 0.1% Tween in
PBS, the macrophages were incubated with a 3% normal goat se-
rum solution in Tris balanced solution, pH 7.3. The cells were
stained with 5 mg/ml of a rabbit antinitrotyrosine polyclonal anti-
body (42) or a rabbit antidinitrophenol (Zymed Laboratories)
polyclonal control antibody for 1 h, followed by a rhodamine-
conjugated goat anti–rabbit polyclonal antibody (Jackson Immu-
noResearch Laboratories) for 1 h. After washing, the coverslips
were mounted with Vectashield® (Vector Laboratories) and ex-
amined with an Olympus IX70 inverted microscope, a Photo-
metrics PXL camera with Kodak KAF1400 chip (6.7 3 6.7 mm
physical pixels giving 67 nm per image pixel with a 3100 oil im-
mersion objective), and a Silicon Graphic O2 computer with
DeltaVision deconvolution software (Applied Precision).
Results
NADPH Oxidase– and iNOS-derived Chemical Species
Contribute to the Antimicrobial Activity of Macrophages for Sal-
monella. Macrophages from iNOS2/2 or gp91phox2/2
mice exerted less antimicrobial activity to S. typhimurium
strain 14028s than macrophages from congenic wild-type
control animals (Fig. 1). Macrophages lacking the NADPH
oxidase were less effective in their ability to contain Salmo-
nella than congenic cells lacking iNOS, suggesting that
O2?2 or its derivatives play a greater role than NO? conge-
ners in Salmonella killing (Fig. 1). The addition of IFN-g
enhanced bactericidal activity of wild-type macrophages
(Fig. 1), and this was correlated with enhanced NO? pro-
duction (Fig. 2). IFN-g did not increase O2?2 production
by wild-type macrophages as measured by reduction of cy-
tochrome c (Fig. 2), and only very modestly increased the
antimicrobial activity of iNOS2/2 macrophages (Fig. 1).
Similar results were obtained for wild-type S. typhimurium
American Type Culture Collection strain 14028s and wild-
type strain M525P (data not shown).
Temporal Differences in iNOS2 and NADPH Oxidase–
mediated Macrophage Cytotoxicity. To study the relative con-
Figure 1. Both ROS and RNS contribute to the antimicrobial activity
of macrophages for Salmonella. Intracellular bacterial counts of untreated
and IFN-g–activated periodate-elicited macrophages from C57BL/6,
iNOS2/2, and gp91phox2/2 mice were compared. Viable intracellular
bacteria were quantified by plating 20 h after the macrophages were chal-
lenged with S. typhimurium 14028s. The data are the mean 6 SEM of 12–18
independent observations obtained on at least four separate days.230 Macrophage Oxidative and Nitrosative Anti-Salmonella Activities
tribution of iNOS and the NADPH oxidase to phago-
cyte-mediated killing of S. typhimurium in more detail, the
cytotoxicity of IFN-g–activated macrophages from wild-
type, iNOS2/2, and gp91phox2/2 mice was studied over a
period of 14 h (Fig. 3). Macrophages from wild-type
C57BL/6 mice exhibited pronounced bactericidal activity
towards Salmonella during the first 6 h after challenge. In
fact, these macrophages eliminated .99% of the original
inoculum during the first 6 h of infection. At later time
points, macrophages exhibited cytostatic behavior, confin-
ing the bacterial burden to a steady level. Although the
NADPH oxidase contributed more than iNOS to overall
macrophage antimicrobial activity, substantial temporal dif-
ferences were observed in the contribution of these sys-
tems. Macrophages deficient in the NADPH oxidase did
not reduce the original inoculum, but were still able to
maintain the bacterial burden at a steady level over time
(Fig. 3 A). In contrast, macrophages deficient in iNOS
considerably reduced the initial inoculum but were unable
to control bacterial replication at later time points (Fig. 3
B). The contribution of iNOS to macrophage antibacterial
activity was detectable as early as 2 h after the initial chal-
lenge (P , 0.05), but became more substantial over time.
In accord with these observations, macrophages deficient
in both the NADPH oxidase and iNOS did not reduce the
inoculum at early time points nor achieve subsequent con-
trol of bacterial replication (Fig. 3 C). A comparison of
macrophages from phox2/2 and iNOS2/2gp91phox2/2 mice
revealed an NO?-dependent antimicrobial activity at later
time points that is independent of the NADPH oxidase.
Production of ROS and RNS in Response to Salmonella.
Production of ROS and RNS by IFN-g–activated mac-
rophages from wild-type, iNOS2/2, and gp91phox2/2
mice was determined over a 10-h period by chemilumi-
nescence using lucigenin and luminol, and by spectropho-
tometry using the Griess reagent (Fig. 4). Production of
ROS by macrophages from wild-type mice was initiated
immediately after phagocytosis, decreasing to undetectable
levels by 6 h thereafter (Fig. 4 A). Lucigenin-dependent
chemiluminescence was three times lower than that medi-
ated by luminol (Fig. 4, A and B), suggesting that a sub-
stantial proportion of the O2?2 formed by the NADPH
oxidase reacts with NO? to form ONOO2. As anticipated,
macrophages from phox2/2 mice exhibited neither lucigenin-
nor luminol-dependent chemiluminescence. Macrophages
from iNOS2/2 mice showed a considerable diminution in
Figure 2. Nitrite and superoxide production by untreated and IFN-g–
activated macrophages. NO2
2 (h) accumulated by macrophages (mf)
from C57BL/6 mice in response to S. typhimurium 14028s was deter-
mined by the Griess reaction at 20 h after challenge, and O2?2 (s) pro-
duction was measured by the reduction of cytochrome c over a 1-h inter-
val 20 h after challenge. The data are the mean 6 SEM of six
independent observations obtained on at least two separate days.
Figure 3. The contribution of iNOS and the NADPH phagocyte oxi-
dase to the antimicrobial activity of macrophages for S. typhimurium varies
over time. The killing activity of IFN-g–activated, periodate-elicited
macrophages from (A–C) C57BL/6, (A) phox2/2, (B) iNOS2/2, and (C)
iNOS2/2gp91phox2/2 mice was recorded over a 1-h period after chal-
lenge with wild-type S. typhimurium strain 14028s. The data are the mean 6
SEM of 3–11 independent observations obtained on at least two separate
days.231 Vazquez-Torres et al.
luminol-dependent chemiluminescence. However, these
macrophages generated a prolonged lucigenin-dependent
chemiluminescence that persisted for the duration of the
experiment.
The rate of NOX production by macrophages from
wild-type mice infected with S. typhimurium increased over
time (Fig. 4 C). In agreement with previous observations
(9), macrophages from gp91phox2/2 mice consistently pro-
duced more NOX than wild-type controls, likely reflecting
a lack of NO? scavenging by O2?2. Macrophages from
iNOS2/2 mice produced very low residual quantities of
NOX, possibly reflecting constitutive NOS activity.
The relative abundance of ROS and RNS produced by
macrophages during the first hour after challenge with S.
typhimurium strain 14028s was characterized further (Fig. 5).
Of the ROS measured, H2O2 was the most abundant, ac-
counting for z0.15  6  0.01 nmol/h/105 macrophages,
closely followed by O2?2 (0.10 6 0.01 nmol/h/105 mac-
rophages; Fig. 5, A and B). Macrophages from iNOS2/2
mice produced more O2?2 and H2O2 in response to Salmo-
nella infection than those from wild-type control animals
(P , 0.05). Macrophages from iNOS2/2 mice appeared to
produce very low levels of NOx that almost exclusively
consisted of NO3
2 (Fig. 5, C and E), suggesting that a sig-
nificant proportion of the NO? attributed to constitutive
NOS might react with O2?2 to form ONOO2 (Fig. 4 B).
Macrophages from gp91phox2/2 mice did not produce de-
tectable quantities of O2?2, H2O2, or chemiluminescence.
Even at the earliest time point, z0.4 nmol/h/105 mac-
rophages of NOX was produced (Fig. 5 C). The majority of
the NO? was oxidized to NO3
2 (z0.3 nmol/h/105 mac-
rophages), although a third was metabolized to NO2
2 (Fig.
5, D and E). After 10 h of infection, the macrophages in-
creased their production of both NO3
2 and NO2
2. NO3
2
production greatly exceeded that of NO2
2 in wild-type,
iNOS2/2, and gp91phox2/2 macrophages. NO? synthe-
sized by constitutive NOS appear to have a negligible con-
tribution to macrophage antimicrobial activity, as the NOS
inhibitor NG-monomethyl l-arginine did not reduce the
inhibition of Salmonella by macrophages from iNOS2/2
mice (data not shown).
Nitrotyrosine Formation in Salmonella-infected Macrophages.
To determine whether ONOO2 produced by macrophages
targets intracellular Salmonella, formation of nitrotyrosine, a
product that can be formed from the reaction of ONOO2
with tyrosine residues, was investigated by immunofluores-
cence microscopy (Fig. 6). In agreement with the biochemi-
cal data (Fig. 4), nitrotyrosine was present in wild-type mac-
rophages infected with wild-type S. typhimurium, but absent
from NADPH oxidase–deficient control macrophages (Fig.
6, A and C). The presence of nitrotyrosine was markedly re-
duced, but not totally absent, in macrophages from iNOS2/2
mice (Fig. 6 B). Nitrotyrosine labeling failed to colocalize
with green fluorescent protein (GFP)-tagged Salmonella in
any instance (Fig. 6, A and B), suggesting that ONOO2 is
formed but may not contribute to bacterial killing. In further
support of this notion, the scavenger uric acid did not dimin-
ish, but rather enhanced by twofold the bactericidal activity
of wild-type macrophages (Fig. 7), suggesting that formation
of ONOO2 is actually detrimental to macrophage anti-Sal-
monella activity.
Discussion
Macrophages can kill or limit the replication of intracel-
lular bacteria by producing antimicrobial peptides, lysoso-
Figure 4. The lucigenin- and luminol-dependent chemiluminescence
and NOX production of Salmonella-infected macrophages vary over time.
The capacity of IFN-g–activated macrophages (mf) to produce ROS and
RNS was measured at selected 1-h intervals over a 10-h period from inde-
pendent wells. The respiratory burst and NOX production were measured
as (A) lucigenin- and (B) luminol-dependent chemiluminescence, and (C)
by the Griess reaction, respectively. The data are the mean 6 SEM of 3–11
independent observations obtained on at least four separate days.232 Macrophage Oxidative and Nitrosative Anti-Salmonella Activities
mal enzymes, ROS, and RNS. The importance of ROS for
macrophage killing of S. typhimurium has been demonstrated
(9, 11, 30); however, the participation of RNS has been less
clear (9, 24, 30, 31). In this work, we demonstrate that al-
though the NADPH oxidase is more essential than iNOS
for Salmonella killing by peritoneal macrophages, iNOS
nevertheless contributes to macrophage antibacterial activity
against  Salmonella in distinct and important ways. The
NADPH oxidase is required for rapid initial Salmonella kill-
ing by macrophages (Fig. 3 A), and iNOS provides a subse-
quent sustained bacteriostatic effect (Fig. 3 B). The failure of
previous investigators to demonstrate macrophage NO?-
dependent anti-Salmonella activity may be attributable to a
reliance on phagocyte killing assays of relatively brief dura-
tion (9, 24, 30). Effector functions of macrophage-derived
nitrogen oxides may explain why iNOS is required for re-
sistance to Salmonella infection (10, 43), despite the apparent
immunosuppressive actions of NO? on T cells (43, 44).
NO?-dependent anti-Salmonella activity was demonstra-
ble in both untreated and IFN-g–treated macrophages,
suggesting that bacterial products such as LPS and DNA
(45) can trigger sufficient NO? synthesis to exert antimi-
crobial activity, at least in partially activated peritoneal cells
elicited by sodium periodate. Nevertheless, the addition of
IFN-g enhances macrophage anti-Salmonella activity pre-
dominantly by increasing NO? production (Figs. 1 and 2).
Although ROS and RNS can exert synergistic antimi-
crobial actions (14, 17–19, 25), they principally act in se-
quential fashion in assays of macrophages infected with Sal-
monella. An early phase of rapid oxidative killing occurs
during the peak respiratory burst, followed by a nitrosative
bacteriostatic phase (Figs. 3 and 4). The functional separa-
tion of these two phases of antimicrobial activity is illus-
trated by the capacity of macrophages deficient in the
NADPH oxidase to maintain their bacterial load at a steady
level despite an inability to reduce the original inoculum.
In contrast, congenic iNOS-deficient macrophages re-
tained early bacterial killing but were unable to maintain
control of subsequent bacterial replication over time. These
temporal differences in the antimicrobial behavior of mac-
rophages were paralleled by the early detection of oxidative
products followed by a later rise in nitrogen oxides (Fig. 4).
The respiratory burst of infected macrophages peaked
shortly after phagocytosis, decreasing rapidly thereafter.
The brief duration of the respiratory burst may result in
part from direct inhibition of NADPH oxidase assembly by
NO? congeners (46–49), as macrophages from iNOS2/2
mice sustained a more prolonged respiratory burst. Addi-
tionally, the increasing abundance of nitrogen oxides over
time may be quenching the oxidative chemistry of O2?2
and ONOO2 (50, 51).
The sequential, functionally distinct, and essential roles
of ROS and RNS in Salmonella killing or inhibition by
macrophages contrast with earlier studies of Leishmania, in
which ROS did not appear to play a role (52). Studies of
Listeria  killing by macrophages have yielded somewhat
conflicting results, with various investigators reporting that
antilisterial activity is RNS independent (9, 53), ROS de-
Figure 5. Macrophage pro-
duction of ROS and RNS in re-
sponse to Salmonella challenge is
largely dependent on the
NADPH oxidase and iNOS. (A)
O2?2, (B) H2O2, and (C) NOX
production were measured by
reduction of cytochrome c,
horseradish peroxidase–depen-
dent oxidation of phenol red,
and the Griess reaction, respec-
tively. A–C represent metabo-
lite production during the first
hour after challenge. D and E
represent NO2
2 and NO3
2 ac-
cumulated over a 1-h interval at
1 and 10 h after challenge. The
data are the mean 6 SEM of 3–10
independent observations ob-
tained on at least two separate
days. mf, macrophages.233 Vazquez-Torres et al.
pendent (9), or either RNS or ROS dependent depending
on the timing of activation (54).
S. typhimurium killing by macrophages appears to be
completely dependent upon the NADPH oxidase. H2O2 is
likely to make a major contribution to bacterial killing, as it
diffuses rapidly through membranes and reacts with transi-
tion metals to form highly toxic hydroxyl radicals. O2?2 has
also been implicated by observations that sodC mutant bac-
teria deficient in periplasmic Cu,Zn-superoxide dismutase
are hypersusceptible to macrophage killing and exhibit re-
duced virulence (25, 55, 56).
NO? makes a relatively minor contribution to early mac-
rophage oxidative killing (Fig. 3). ONOO2, a reactive mol-
ecule capable of mediating 1- and 2-electron oxidations (16)
with potent in vitro microbicidal activity for E. coli, S. typhi-
murium, and C. albicans (17, 18, 25), might account for this
activity. However, intracellular bacteria fail to colocalize
with nitrotyrosine (Fig. 6), a molecular signature that can be
associated with ONOO2 synthesis (15, 42), suggesting that
ONOO2 may not be responsible for early bactericidal ef-
fects. The scavenger uric acid actually potentiates Salmonella
killing (Fig. 7), further indicating that ONOO2 production
by Salmonella-containing macrophages may be responsible
for host cell autotoxicity rather than antimicrobial activity.
Synergistic actions of metal ions, NO? redox congeners, and
H2O2, or the production of singlet oxygen from the reac-
tion of NO? and H2O2, are alternative mechanisms by
which NO?-derived species may potentiate NADPH oxi-
dase–dependent macrophage killing (19, 57, 58).
At this time, the identity of the nitrogen oxides responsi-
ble for the sustained NO?-dependent inhibition of bacterial
growth are not known, but possibilities include NO? itself,
N2O3, and S-nitrosothiols, which have been shown to ex-
ert bacteriostatic activity for S. typhimurium in vitro (13,
14). The predominant accumulation of NO3
2 rather than
NO2
2 at late time points in the macrophage assay when
ONOO2 is no longer detectable suggests that dioxygenase
activity (59) might be involved in NO? oxidation.
Of the three NOS isoforms that can catalyze the enzy-
matic production of NO?, iNOS is most closely associated
with antimicrobial activity. The contribution of cNOS to
the antibacterial activity of macrophages in this study was
negligible. The small quantity of NO? attributed to cNOS
was oxidized to NO3
2 (z0.12 nmol/h/105 macrophages).
A small amount of nitrotyrosine staining and NOx produc-
tion detectable in iNOS-deficient macrophages infected
with  Salmonella suggests that NO? derived from cNOS can
react with O2?2, as has been demonstrated in murine Myco-
Figure 6. Nitrotyrosine stain-
ing fails to colocalize with bacte-
ria in Salmonella-containing mac-
rophages. The presence of
nitrotyrosine (red) was examined
by immunofluorescence micros-
copy of IFN-g–activated mac-
rophages from (A) C57BL/6, (B)
iNOS2/2, and (C) gp91phox2/2
mice that were challenged in
vitro with GFP-expressing S. ty-
phimurium (green). The pictures
are representative of data ob-
tained on two separate days.
Figure 7. Uric acid improves killing of Salmonella by macrophages. 1
mmol uric acid enhances killing of Salmonella by (A) IFN-g–activated
macrophages, but this enhancement is iNOS dependent (B). The data
are the mean 6 SEM of six independent observations obtained on two
separate days.234 Macrophage Oxidative and Nitrosative Anti-Salmonella Activities
plasma pulmonis infection (60). These results might indicate
that murine mononuclear phagocytes are able to express
both inducible and constitutive NOS, as has been sug-
gested by others (61, 62), although functional cNOS has
not yet been definitively demonstrated in primary murine
peritoneal macrophages.
In conclusion, both the NADPH phagocyte oxidase and
iNOS contribute to the ability of macrophages to inhibit or
kill  S. typhimurium. Analysis of murine peritoneal mac-
rophages reveals a temporally coordinated action of ROS
and RNS. Rapid bacterial killing coinciding with produc-
tion of O2?2 by the NADPH phagocyte oxidase is fol-
lowed by a prolonged period of inhibition of bacterial
growth associated with the production of iNOS-derived
nitrosative species. The sequential roles of oxidative and
nitrosative phagocyte antimicrobial mediators in vitro are
mirrored by the temporal relationship of early NADPH
oxidase–dependent and late iNOS-dependent antimicro-
bial effector mechanisms observed during murine Salmo-
nella infection in vivo (10).
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